Creative Planning Purchases 3,724 Shares of Genpact Limited $G

Creative Planning raised its position in shares of Genpact Limited (NYSE:G) by 10.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,620 shares of the business services provider’s stock after acquiring an additional 3,724 shares during the period. Creative Planning’s holdings in Genpact were worth $1,700,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the business. Steph & Co. bought a new stake in Genpact in the second quarter worth $37,000. Huntington National Bank grew its stake in Genpact by 208.2% in the second quarter. Huntington National Bank now owns 906 shares of the business services provider’s stock worth $40,000 after purchasing an additional 612 shares in the last quarter. SVB Wealth LLC purchased a new position in shares of Genpact during the first quarter valued at $41,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in Genpact by 104.9% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 922 shares of the business services provider’s stock valued at $41,000 after purchasing an additional 472 shares during the period. Finally, Kestra Investment Management LLC bought a new position in Genpact in the first quarter worth approximately $56,000. Institutional investors own 96.03% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on G. Wall Street Zen upgraded shares of Genpact from a “hold” rating to a “buy” rating in a research note on Saturday, November 15th. Needham & Company LLC lifted their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a research note on Friday, August 8th. JPMorgan Chase & Co. lowered their target price on Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 20th. Citigroup raised shares of Genpact to a “hold” rating in a report on Thursday, October 23rd. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Genpact in a research report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $51.13.

Insider Activity at Genpact

In other news, SVP Sameer Dewan sold 26,531 shares of the stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $44.70, for a total transaction of $1,185,935.70. Following the completion of the sale, the senior vice president owned 62,617 shares in the company, valued at approximately $2,798,979.90. This represents a 29.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total value of $2,384,800.00. Following the sale, the chief executive officer directly owned 295,246 shares of the company’s stock, valued at approximately $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 161,183 shares of company stock worth $6,970,760 over the last 90 days. 3.07% of the stock is owned by corporate insiders.

Genpact Stock Performance

Shares of G stock opened at $44.25 on Thursday. Genpact Limited has a one year low of $37.49 and a one year high of $56.76. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.51. The firm’s 50 day moving average price is $41.33 and its 200-day moving average price is $43.00. The firm has a market cap of $7.63 billion, a P/E ratio of 14.27, a P/E/G ratio of 1.43 and a beta of 0.85.

Genpact (NYSE:G) last posted its quarterly earnings data on Thursday, November 6th. The business services provider reported $0.97 EPS for the quarter, beating the consensus estimate of $0.90 by $0.07. Genpact had a net margin of 11.01% and a return on equity of 22.55%. The business had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm posted $0.85 earnings per share. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS. Q4 2025 guidance at 0.930-0.940 EPS. As a group, equities research analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Tuesday, December 9th. Genpact’s dividend payout ratio (DPR) is 21.94%.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.